Gideon Blumenthal

Company: Merck
Job title: Vice President of Global Regulatory Affairs for Oncology
Seminars:
10.05 | 7.05 – Regulatory Guidance for Liquid Biopsy Applications in Clinical Programs 10:05 am
Data assembly considerations for regulatory review Regulatory considerations for varying LBx applications and profiling technologies Endpoint considerations in clinical trial design Establishing ctDNA changes as a surrogate marker in the metastatic and adjuvant settingsRead more
day: Day Three